Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application For The Treatment Of Behavioral Addictions May 26, 2022
atai Life Sciences: Unparalleled Diversification With 10 Psychedelic Compounds Going Into Clinical Trials In 2022 May 25, 2022
Creso Pharma Secures Agreement With Australia’s Leading Tattoo Aftercare Products Company May 24, 2022
Numinus’ Ongoing Collaboration With Health Canada Spurs Mindspace Clinic Approval In Quebec May 24, 2022
Awakn Life Sciences CEO, Anthony Tennyson, Joins Dustin Robinson of Iter Investments for ‘The Investor… May 24, 2022
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting May 23, 2022
Trade To Black Podcast: Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology May 22, 2022
